Sumary of Commonly prescribed gout medication found effective against COVID-19:
- Woman hand with joint pain and pills on table A conventional gout medication that is utilised widely around the world has proven to be effective at combatting COVID-19, potentially adding a new weapon in defeating the virus.
- The team discovered that probenecid – a gout medication – displayed broad antiviral properties that make it a prime candidate to fight SARS-CoV-2 infection.
- The gout medication may also aid in treating common and deadly respiratory viruses such as RSV and flu.
- Probenecid is approved by the FDA and is widely available throughout parts of the world, demonstrates minimal side effects and has been implemented on the market for over 40 years.
- Ralph Tripp, the lead author of the study and GRA Eminent Scholar of Vaccine and Therapeutic Studies in UGA’s College of Veterinary Medicine, said: “There’s really nothing out there to safely fight these viruses.
- This antiviral works for all RNA respiratory viruses we tested, including SARS-CoV-2. RSV, coronavirus, and flu all circulate in the same season.
- The bottom line is you can potentially reduce infection and disease using this one oral drug.
- During clinical development at the TrippBio, Tripp identified that the gout medication works as a prophylactic prior to virus exposure and a post-exposure treatment in animal models against SARS-CoV-2 and flu.